Here is another biotech success story:
They developed 3-T-C (Epivir) and licensed to Glaxo/Wellcome for 14% royalty. Epivir is an essential 1/3 of the so-called "cocktail" of 3 drugs recently found to have decimating effect on HIV. (See WSJ: 6/14/96, p.1!)
This in itself is a great success. The other essential 1/3 is Retrovir (AZT) also from Glaxo/Wellcome. The final 1/3 is a drug made by ABT, MRK, and one other I can't think of offhand. As well, the most powerful of these "protease inhibitors" is nearing FDA approval (or disapproval): AGPH. Another unsung hero.
This is the only company I have ever found whose clinical studies have progressed to the point where they have actual hope of creating a drug to treat cryptospiridium (wasting syndrome). And they have a Hepatitis drug in the making.
Is anyone else interested in this Canadian company with good tie-ins to the major pharmaceuticals? |
